Advertisement
Screener

ALPHA TEKNOVA, INC. (TKNO) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.8 / 5 stars · 68/120 Roast Me

ALPHA TEKNOVA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

ALPHA TEKNOVA, INC. (TKNO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2024-11-08

  • ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-09-30 was 0.00%.
  • ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
  • ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-09-30 was 0.00%.
  • ALPHA TEKNOVA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-06-30 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month
2024-09-300.00%
10-Q · filed 2024-11-08
0.00%
10-Q · filed 2024-11-08
2024-06-300.00%
10-Q · filed 2024-08-13
2024-03-310.00%
10-Q · filed 2024-05-13
2023-09-300.00%
10-Q · filed 2024-11-08
0.00%
10-Q · filed 2024-11-08
2023-06-300.00%
10-Q · filed 2024-08-13
0.00%
10-Q · filed 2024-08-13
2023-03-310.00%
10-Q · filed 2024-05-13
2022-09-300.00%
10-Q · filed 2022-11-14
0.00%
10-Q · filed 2022-11-14
2022-06-300.00%
10-Q · filed 2022-08-11
0.00%
10-Q · filed 2022-08-11
2022-03-310.00%
10-Q · filed 2022-05-12
2021-09-300.00%
10-Q · filed 2022-11-14
0.00%
10-Q · filed 2022-11-14
2021-06-300.00%
10-Q · filed 2022-08-11
0.00%
10-Q · filed 2022-08-11
2021-03-310.00%
10-Q · filed 2022-05-12
2020-09-300.00%
10-Q · filed 2021-11-12
0.00%
10-Q · filed 2021-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92